Related Experiment Video
Updated: Aug 26, 2026

In Silico Clinical Trials for Cardiovascular Disease
Published on: May 27, 2022
Cluster-Randomized Trials - Insights from Cardiovascular Prevention
Ravi Vazirani1,2, Borja Ibanez2,3, Deepak L Bhatt1
1Mount Sinai Fuster Heart Hospital, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
None:
AbstractCluster-randomized trials are increasingly relevant to the evaluation of preventive and treatment strategies for chronic disease, especially when interventions are delivered through groups, practices, communities, or health systems rather than individuals. Using cardiovascular prevention as an illustrative example, we review key design, conduct, and analytic issues that determine when cluster randomization is appropriate and how such trials should be designed, analyzed, and interpreted. Particular attention is given to the choice of the unit of randomization, protection of internal validity, implications for statistical efficiency, and alignment of outcomes and analyses with the level and mechanism of intervention delivery. A clear understanding of these principles should strengthen the design, interpretation, and policy relevance of cluster-randomized trials.
Related Concept Videos
Randomized Experiments
Simple randomization
Simple...
Coronary Artery Disease IV: Preventive Measures
Clinical Trials: Overview
Study Designs in Epidemiology
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and case-control studies.
Clinical Trials
There are four phases in a clinical trial. A phase one...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...